BioSpace News Archive

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro’s Chairman, CEO and President will participate in Citi Bank’s Head Shoulders Knees and Toes Conferenc

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today announced that on November 23, 2020 , the NYSE American LLC (“NYSE American”), the Company’s curre

Prelude Corporation, a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced that it has signed an agreement to become a provider in the America’s Choice Provider Network.

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-gene

Expands operations of exclusive ‘on-demand’ supply service beyond the UK into France Enables continuity of supply for global clinical trial customers wanting EU product Long term partnerships between Accord Healthcare and both Clinical Services and Global Access, demonstrating strong position serving both pharma and HCPs’ needs

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces participation at the following upcoming conferences: Piper Sandler 32 nd Annual Virtual Healthcare Conference Tuesday, December 1, 2020 Evercore ISI 3 rd Annual HealthCONx Conference Gaur

A team from the Institut national de la recherche scientifique has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis.

Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET.

Secure AI Labs (SAIL), the healthcare data security company offering a secure, easy-to-manage, and auditable solution to track and trace the use of patient data in collaborative research, today announced the appointment of Omar Hussain to its Board of Directors.